MENU
Aviva Swiss
Frag 176-191 is a modified amino acid sequence of growth hormone. The lipolytic activity of Frag 176-191 was confirmed by several published studies. The compound acts directly on the adipose fat tissues, increasing lipolysis and decreasing lipogenesis.
Frag 176-191 is a modified amino acid sequence of growth hormone. The lipolytic activity of Frag 176-191 was confirmed by several published studies. The compound acts directly on the adipose fat tissues, increasing lipolysis and decreasing lipogenesis.
IGF1 LR3 (Long R3 Insulin-like Growth Factor) is a polypeptide hormone with properties similar to insulin. However, LR3 is a modified form of IGF1 to increase half-life and to prevent deactivation due to protein binding.
CJC-1295, a modified form of GRF 1-29 NO DAC, is a peptide hormone that contains 29 amino acids. Since the 2000’s, the compound has been studied to explore the lipolytic properties, particularly the visceral fat elimination.
Adipotide is a peptidomimetic substance with a structural sequence of CKGGRAKDC-GG-D(KLAKLAK)2. Adipotide selectively acts and shrinks the adipose tissue fat supplying blood vessels and induce apoptosis. In primates and rodents, Adipotide significantly induce weight loss by rapid fat elimination.